Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustin in Refractory Soft Tissue Sarcoma
NCT00204620Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bendamustine in soft tissue sarcoma (STS), sponsored by University Hospital Tübingen. Primary endpoints: Efficacy of bendamustin and Treatment toxicity. Started Mar 2002; status: completed.
02
Drugs
bendamustine
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00204620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00204620.